These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Time-dependent inactivation of aromatase by 6-alkylandrosta-1,4-diene-3,17-diones. Effects of length and configuration of 6-alkyl group. Numazawa M, Oshibe M, Yamaguchi S, Tachibana M. J Med Chem; 1996 Mar 01; 39(5):1033-8. PubMed ID: 8676338 [Abstract] [Full Text] [Related]
5. Substituted C19 steroid analogs as inhibitors of aromatase. Brueggemeier RW, Snider CE, Counsell RE. Cancer Res; 1982 Aug 01; 42(8 Suppl):3334s-3337s. PubMed ID: 7083196 [Abstract] [Full Text] [Related]
9. Structure-activity relationships of a new family of steroidal aromatase inhibitors. 1. Synthesis and evaluation of a series of analogs related to 19-[(methylthio)methyl]androstenedione (RU54115). Lesuisse D, Gourvest JF, Benslimane O, Canu F, Delaisi C, Doucet B, Hartmann C, Lefrançois JM, Tric B, Mansuy D, Philibert D, Teutsch G. J Med Chem; 1996 Feb 02; 39(3):757-72. PubMed ID: 8576919 [Abstract] [Full Text] [Related]
11. Synthesis and evaluation of 4-substituted-4-androstene-3,17-dione derivatives as aromatase inhibitors. Abul-Hajj YJ, Liu XP, Hedge M. J Steroid Biochem Mol Biol; 1995 Aug 10; 54(3-4):111-9. PubMed ID: 7662584 [Abstract] [Full Text] [Related]
12. Synthesis, structure elucidation, and biochemical evaluation of 7 alpha- and 7 beta-arylaliphatic-substituted androst-4-ene-3,17-diones as inhibitors of aromatase. O'Reilly JM, Li N, Duax WL, Brueggemeier RW. J Med Chem; 1995 Jul 21; 38(15):2842-50. PubMed ID: 7636845 [Abstract] [Full Text] [Related]
13. Aromatase inhibitors: effect of ring A and ring B unsaturation on aromatase inhibition by 4-thiosubstituted derivatives of 4-androstene-3,17-dione. Abul-Hajj YJ, Liu XP, Hedge M. Steroids; 1995 May 21; 60(5):423-7. PubMed ID: 7570717 [Abstract] [Full Text] [Related]
14. Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids. Takahashi M, Yamashita K, Numazawa M. Steroids; 2010 Apr 21; 75(4-5):330-7. PubMed ID: 20096721 [Abstract] [Full Text] [Related]
15. Synthesis and structure-activity relationships of 6-phenylaliphatic-substituted C19 steroids having a 1,4-diene, 4,6-diene, or 1,4,6-triene structure as aromatase inhibitors. Numazawa M, Yamaguchi S. Steroids; 1999 Mar 21; 64(3):187-96. PubMed ID: 10400379 [Abstract] [Full Text] [Related]
16. Comparative studies of aromatase inhibitors in cultured human breast cancer cells. MacIndoe JH, Woods GR, Etre LA, Covey DF. Cancer Res; 1982 Aug 21; 42(8 Suppl):3378s-3381s. PubMed ID: 7083203 [Abstract] [Full Text] [Related]
17. Probing the binding pocket of the active site of aromatase with 6-ether or 6-ester substituted androst-4-ene-3,17-diones and their diene and triene analogs. Numazawa M, Shelangouski M, Nagasaka M. Steroids; 2000 Dec 21; 65(12):871-82. PubMed ID: 11077085 [Abstract] [Full Text] [Related]
18. A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase. Covey DF, Hood WF. Cancer Res; 1982 Aug 21; 42(8 Suppl):3327s-3333s. PubMed ID: 7083195 [Abstract] [Full Text] [Related]
19. Structure-activity relationships of 2alpha-substituted androstenedione analogs as aromatase inhibitors and their aromatization reactions. Numazawa M, Handa W, Hasegawa C, Takahashi M. J Steroid Biochem Mol Biol; 2005 Dec 21; 97(4):353-9. PubMed ID: 16209922 [Abstract] [Full Text] [Related]
20. Further studies on 6-alkylandrost-4-ene-3,17-diones as aromatase inhibitors: elongation of the 6-alkyl chain. Numazawa M, Oshibe M. Steroids; 1995 Aug 21; 60(8):506-11. PubMed ID: 8539792 [Abstract] [Full Text] [Related] Page: [Next] [New Search]